文献速递慢性肾脏病

普通人群中炎症、肾功能与慢性肾脏病的新型生物标志物

Novel biomarkers of inflammation, kidney function and chronic kidney disease in the general population.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

在KORA F4(n=1110)和ESTHER(n=1672)两个独立人群研究中,用邻近延伸分析技术检测炎症生物标志物。KORA F4发现52/71种标志物与基于血肌酐的eGFR负相关,42种在ESTHER中重复验证;meta分析显示9种标志物与CKD发病独立相关。通路分析提示固有与适应性免疫细胞交叉对话参与其中。

要点

  • 多种炎症生物标志物与eGFR呈负相关,并在独立人群中可重复验证。
  • 9种炎症标志物与CKD发病独立于心血管肾脏危险因素相关。
  • 通路分析提示固有免疫与适应性免疫细胞交叉对话参与CKD发生。

核心结论

  • 新型和已知的炎症生物标志物与肾功能可重复相关,未来需在独立队列中研究其临床效用和分子机制。

研究设计与样本

  • 采用两个独立人群为基础的KORA F4(发现集,n=1110,平均年龄70.3岁,48.7%男性)和ESTHER(重复集,n=1672,平均年龄61.9岁,43.6%男性)研究。
  • 使用邻近延伸分析技术检测血清生物标志物水平,用线性回归和logistic回归模型分析生物标志物与基线eGFR及CKD发病的关联,并校正心血管肾脏危险因素。
  • 对两项研究的前瞻性分析独立结果进行合并,采用错误发现率校正多重检验(PFDR < 0.05)。

主要发现

  • 在KORA F4发现研究中,71种炎症生物标志物中有52种与基于血肌酐的eGFR呈负相关,顶级标志物包括CD40、TNFRSF9和IL10RB。
  • 52种标志物中有42种在ESTHER研究中得到重复验证。
  • 在KORA(n=142,平均随访6.5年)和ESTHER(n=103,平均随访8年)研究的meta分析中,42种标志物中有9种与CKD发病独立于心血管肾脏危险因素相关。
  • 通路分析揭示炎症和免疫调节过程参与,反映固有免疫与适应性免疫细胞的交叉对话。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammatory processes have been implicated in the development of chronic kidney disease (CKD). We investigated the association of a large panel of inflammatory biomarkers reflecting aspects of immunity with kidney function and CKD incidence. METHODS: We used data from two independent population-based studies, KORA F4 (discovery, n = 1110, mean age 70.3 years, 48.7% male) and ESTHER (replication, n = 1672, mean age 61.9 years, 43.6% male). Serum levels of biomarkers were measured using proximity extension assay technology. The association of biomarkers with estimated glomerular filtration rate (eGFR) at baseline and with incident CKD was investigated using linear and logistic regression models adjusted for cardiorenal risk factors. Independent results from prospective analyses of both studies were pooled. The significance level was corrected for multiple testing by false-discovery rate (PFDR < 0.05). RESULTS: In the KORA F4 discovery study, 52 of 71 inflammatory biomarkers were inversely associated with eGFR based on serum creatinine. Top biomarkers included CD40, TNFRSF9 and IL10RB. Forty-two of these 52 biomarkers were replicated in the ESTHER study. Nine of the 42 biomarkers were associated with incident CKD independent of cardiorenal risk factors in the meta-analysis of the KORA (n = 142, mean follow-up 6.5 years) and ESTHER (n = 103, mean follow-up 8 years) studies. Pathway analysis revealed the involvement of inflammatory and immunomodulatory processes reflecting cross-communication of innate and adaptive immune cells. CONCLUSIONS: Novel and known biomarkers of inflammation were reproducibly associated with kidney function. Future studies should investigate their clinical utility and underlying molecular mechanisms in independent cohorts.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Nano J, Schöttker B, Lin JS, et al. Novel biomarkers of inflammation, kidney function and chronic kidney disease in the general population. Nephrol Dial Transplant. 2022. PMID: 34612501. doi:10.1093/ndt/gfab294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。